FDA Drug Application (091281) for CYCLOBENZAPRINE HYDROCHLORIDE by TWI PHARMS INC

Back to FDA Applications sponsored by TWI PHARMS INC

Application Number091281
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage15MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCYCLOBENZAPRINE HYDROCHLORIDE
Active IngredientCYCLOBENZAPRINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient CYCLOBENZAPRINE HYDROCHLORIDE3


Back to FDA Applications sponsored by TWI PHARMS INC